To visit The Galley website: http://www.thegalleysr.com
QVI, Inc., operating as “The Galley”, is a 10,000 sq. ft. cannabis infused product manufacturer located in Sonoma CA. The fully license facility, is built to the high standards of the FDA and the California Department of Public Health. It is focused on high demand areas of production; edibles, topicals, tinctures, chocolates, hard candies, gummies, beverages, prerolls and flower packaging. FinCanna has signed a binding letter of intent to increase its investment to 100% ownership of QVI Inc that will replace its existing royalty investment and as announced in Nov. 2021 that QVI is now actively pursuing three significant steams of revenue: continued co-manufacturing; a Strategic Agreement with multi-award-winning Cherry Kola Farms; and its “manufacturer to retail” model focused on its own branded, low priced, high margin products.
To visit the ezGreen Compliance website: https://www.ezgreencompliance.com/
ezGreen Compliance offers a state-of-the-art enterprise compliance and point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. The ezGreen software is the only HIPAA (Health Insurance Portability and Accountability Act) certified point-of-sale software in the market. In August 2020, FinCanna acquired from its former royalty portfolio company 100% of the assets and economic interests of ezGreen and is currently focused on growing its business in California and certain other states.
To visit the Coachella Manufacturing website: https://www.coachellamanufacturing.com/
Cultivation Technologies Inc. (“CTI”) operating as “Coachella Manufacturing”, is a multi-award winning extraction and manufacturing enterprise located in Palm Desert, California that provides high quality Butane Hash Oil (BHO) concentrates as well as higher velocity and higher volume ethanol-based and propane-based products for white label manufacturing, toll processing and packaging to hand-selected brands and cultivators in CA. Under the Royalty Agreement (fully funded), FinCanna earns a perpetual royalty of 10% of CTI’s revenues, of which 5% is paid in cash and 5% deferred until certain triggering events. On August 27, 2021, CTI issued correspondence to its stakeholders that due to a number of challenges, including an extremely competitive environment and ongoing legal issues that it intended to wind down operations.